New treatment option for patients with mCRPC ConferenceESMO 2020 TypePeer-reviewed article 25 November 2020 14:50
PARP inhibition in selected patients slows progression on advanced prostate cancer Presented ByProf. Maha Hussain, Northwestern University, Chicago, USA TrialPhase 3, PROfound ConferenceESMO 2019 TypePeer-reviewed article 26 November 2019 21:24